Bookmark

Add to MyYahoo RSS

Dendreon News

News on Dendreon (Ticker: DNDN) continually updated from thousands of sources around the net.

Thursday Jul 24 | Seeking Alpha

3 Convincing Reasons To Buy Dendreon

Dendreon fell after first-quarter results failed to impress, but the company has solid opportunity in the prostate cancer drug market.

Comment?

Related Topix: Prostate Cancer, Health

Tue Jul 22, 2014

AmericanBankingNews.com

Dendreon Receives Consensus Recommendation of "Hold" from Analysts

Shares of Dendreon have been given an average rating of "Hold" by the nineteen ratings firms that are presently covering the stock, Analyst Ratings Network reports .

Comment?

Sat Jul 19, 2014

GuruFocus.com

Why You Should Buy Dendreon's Drop

Biotechnology organization Dendreon's performance haasn't been extra ordinary in 2014.

Comment?

Wed Jul 16, 2014

AmericanBankingNews.com

Dendreon Short Interest Up 3.8% in June

Dendreon was the target of a large growth in short interest during the month of June.

Comment?

Mon Jul 07, 2014

Seeking Alpha

New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

Followers of Dendreon may have noticed that since May, the stock has halted its downward march toward zero, finding support at $2.

Comment?

Related Topix: Oncology, Prostate Cancer, Health

Seeking Alpha

What Does Dendreon Need To Succeed?

I know that my coverage of biotech Dendreon has been heavily slanted towards the negative side.

Comment?

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••